vitamin-b-12 and Hypertriglyceridemia

vitamin-b-12 has been researched along with Hypertriglyceridemia* in 2 studies

Trials

1 trial(s) available for vitamin-b-12 and Hypertriglyceridemia

ArticleYear
Serum homocysteine increases after therapy with fenofibrate or bezafibrate.
    Lancet (London, England), 1999, Jul-17, Volume: 354, Issue:9174

    A 44% and 17.5% increase of homocysteine occurred in patients treated either with fenofibrate or bezafibrate. The increase was not explained by changes in vitamin concentrations but may be related to renal function.

    Topics: Adult; Bezafibrate; Chromatography, High Pressure Liquid; Fenofibrate; Folic Acid; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Pilot Projects; Pyridoxine; Vitamin B 12

1999

Other Studies

1 other study(ies) available for vitamin-b-12 and Hypertriglyceridemia

ArticleYear
A combined supplementation of vitamin B12 and omega-3 fatty acids across two generations improves cardiometabolic variables in rats.
    Food & function, 2016, Sep-14, Volume: 7, Issue:9

    Our earlier studies indicate that micronutrients (vitamin B12, folic acid) and omega-3 fatty acids especially docosahexaenoic acid (DHA) are interlinked in one carbon cycle. The present study examines the effects of a sustained vitamin B12 deficiency/supplementation in the presence of omega-3 fatty acids across two generations on the pregnancy outcome and cardiometabolic profile [blood pressure, plasma lipid profile (cholesterol and triglycerides), plasma/liver fatty acid profile and hepatic lipid metabolism] in the second generation adult Wistar rat offspring. Two generations of animals were fed the following diets: control; vitamin B12 deficient; vitamin B12 supplemented; vitamin B12 deficient diet supplemented with omega-3 fatty acids; vitamin B12 and omega-3 fatty acid supplemented diets. Male offspring were sacrificed at 3 months of age. Vitamin B12 deficiency lowered the weight gain (p < 0.01) during pregnancy, increased systolic (p < 0.05) and diastolic (p < 0.01) blood pressure, and lowered the levels of plasma/liver DHA (p < 0.05 for both) but did not affect the lipid profile. Vitamin B12 supplementation showed weight gain, blood pressure and the fatty acid profile similar to the control. However, it increased (p < 0.05) the levels of plasma triglycerides. Omega-3 fatty acid supplementation to the vitamin B12 deficient group lowered the weight gain although the levels of cardiometabolic variables were comparable to the control. Omega-3 fatty acid supplementation in the presence of vitamin B12 improved the pregnancy outcome and all cardio-metabolic variables. Our study highlights the adverse effects of sustained vitamin B12 deficiency across two generations on the pregnancy outcome, fatty acid profile and blood pressure while a combined supplementation of vitamin B12 and omega-3 fatty acids is beneficial.

    Topics: Animals; Cardiovascular Diseases; Deficiency Diseases; Dietary Supplements; Fatty Acids, Omega-3; Female; Fetal Development; Hypertriglyceridemia; Lactation; Liver; Male; Maternal Nutritional Physiological Phenomena; Organ Size; Overweight; Pregnancy; Rats, Wistar; Vitamin B 12; Vitamin B 12 Deficiency; Weaning; Weight Gain

2016